Overview

Performance
Performance
-
Returns
| 1y | 3y | 5y | 10y | |
|---|---|---|---|---|
|
Total Return (%)
as of Dec 31, 2025 |
20.32 | 13.32 | 10.62 | 10.46 |
|
Return w/ Sales Charge (%)
as of Dec 31, 2025 |
19.32 | 13.32 | 10.62 | 10.46 |
|
Benchmark (%)
as of Dec 31, 2025 |
15.91 | 13.90 | 11.33 | 10.53 |
| YTD | 1m | 3m | 1y | 3y | 5y | 10y | |
|---|---|---|---|---|---|---|---|
|
Total Return (%)
as of Dec 31, 2025 |
20.32 | 1.90 | 4.82 | 20.32 | 45.51 | 65.63 | 170.52 |
|
Return w/ Sales Charge (%)
as of Dec 31, 2025 |
19.32 | 0.90 | 3.82 | 19.32 | 45.51 | 65.63 | 170.52 |
|
Benchmark (%)
as of Dec 31, 2025 |
15.91 | 0.68 | 3.81 | 15.91 | 47.76 | 70.99 | 172.13 |
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Total Return (%) | 19.00 | -5.07 | 11.45 | 8.52 | 20.32 |
| Annual w/ Sales Charge (%) | 18.00 | -6.02 | 10.45 | 7.52 | 19.32 |
| Benchmark (%) | 25.16 | -7.54 | 11.46 | 14.37 | 15.91 |
Performance is shown after deduction of ongoing charges. Any entry and exit charges are excluded from the calculation.
Key Facts
Key Facts
Portfolio Characteristics
Portfolio Characteristics
Fees
Fees
| Gross Expense Ratio | 1.83% |
| Net Expense Ratio | 1.83% |
Net Expense Ratio excluding Investment Related Expenses is 1.14%
- Acquired Fund Fees and Expenses 0.69%
- Interest expense 0.00%
Holdings
Holdings
| Name | Weight (%) |
|---|---|
| CITIGROUP INC | 3.36 |
| WELLS FARGO & COMPANY | 3.27 |
| CARDINAL HEALTH INC | 2.81 |
| SS&C TECHNOLOGIES HOLDINGS INC | 2.62 |
| AMAZON.COM INC | 2.58 |
| Name | Weight (%) |
|---|---|
| BECTON DICKINSON AND COMPANY | 2.44 |
| FIRST CITIZENS BANCSHARES INC (DELAWARE) | 2.33 |
| INTERCONTINENTAL EXCHANGE INC | 2.21 |
| MEDTRONIC PLC | 2.19 |
| CVS HEALTH CORP | 2.13 |
Exposure Breakdowns
Exposure Breakdowns
Allocations are subject to change.
Portfolio Managers
Portfolio Managers
ESG Integration
ESG Integration
This fund does not seek to follow a sustainable, impact or ESG investment strategy. For more information regarding the fund's investment strategy, please see the fund's prospectus or, as applicable, shareholder report.